Abstract:The biological behaviors of residual hepatoma cells after transarterial embolization therapy, which exist in a hypoxic or even anaerobic tumor microenvironment, differ from the tumor cells under normoxic conditions. This study aimed to use a phage display peptide library for in vivo and in vitro screening to obtain a peptide which could specifically bind to hypoxic hepatoma cells, allowing further targeted diagnosis and treatment for liver cancer. In this study, hypoxic hepatoma cells HepG2 (targeted cells), and normal liver cells HL-7702 (control cells), were utilized to perform three rounds of in vitro screening using a phage-displayed 7-mer peptide library. In addition, hypoxic HepG2 were subcutaneously injected into nude mice to establish a hepatocarcinoma model, followed by performing three rounds of in vivo screening on the phages identified from the in vitro screening. The products from the screening were further identified using ELISA and immunofluorescence staining on cells and tissues. The results indicated that the P11 positive clone had the highest binding effect with hypoxic hepatoma cells. The sequence of the exogenous insert fragment of P11 positive clone was obtained by sequencing: GSTSFSK. The binding assay indicated that GSTSFSK could specifically bind to hypoxic hepatoma cells and hepatocarcinoma tissues. This 7-mer peptide has the potential to be developed as an useful molecular to the targeting diagnosis and treatment of residual hepatoma cells after transarterial chemoembolization.

In Vivo Screening with Ph . D .7 TM and Identification of Ovarian Cancer A 2780 Cell Targeted

A Novel Peptide Specifically Targeting Ovarian Cancer Identified by in Vivo Phage Display.

In Vitro Screening of Ovarian Tumor Specific Peptides from a Phage Display Peptide Library

Screening and Identification of a Specific Binding Peptide to Ovarian Cancer Cells from a Phage-Displayed Peptide Library

Selection and identification of a specific peptide binding to ovarian cancer cells from a phage-displayed peptide library

The selection and primary characterization of a 12mer peptide targeting ovarian cancer cells

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

Cell Adhesion and Invasion Inhibitory Effect of an Ovarian Cancer Targeting Peptide Selected Via Phage Display in Vivo

Selection of the Peptides Specifically Binding to Hepatoma by Using Phage Display in Vivo

Identification of a Peptide for Folate Receptor Alpha by Phage Display and Its Tumor Targeting Activity in Ovary Cancer Xenograft

Screening and Characterization of Multipeptide Binding Specifically to Gastric Cancer Cells by Phage Peptide Library

In Vivo Selection of Phage Sequences and Characterization of Peptide-Specific Binding to Breast Cancer Cells

In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library

[Phage Display Random Peptide Library for Screening the Peptides That Specifically Bind to Hepatocellular Carcinoma Cells].

Ph.D. -C7CTM Phage Display Peptide Library Selection on Gastric Cancer MDR Cells to Yield Specific Binding Peptides

Screening and Characterization of Multi-Peptide Binding Specifically to Hepatocellular Carcinoma Cells by Phage Peptide Library

Screening and identification of a specific peptide for targeting hypoxic hepatoma cells

Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library

Selection and Characterization of a Peptide Specifically Targeting to Gastric Cancer Cell Line SGC-7901 Using Phage Display

Phage Display Selection of Peptides That Inhibit Metastasis Ability of Gastric Cancer Cells with High Liver-Metastatic Potential.